Type | Public | |
Founded | 2001 | |
HQ | Boston, MA, US | Map |
Website | aveooncology.com | |
Employee Ratings |
USD | |
---|---|
Revenue (Q1, 2021) | 1.9m |
Net income (Q1, 2021) | (22.1m) |
EBIT (Q1, 2021) | (19.1m) |
Market capitalization (24-Jun-2022) | 226.2m |
Closing stock price (24-Jun-2022) | 6.6 |
Cash (31-Mar-2021) | 121.4m |
EV | 161.7m |
USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 164.8m | 19.3m | 1.3m | 18.1m | 19.0m | 2.5m | 7.6m | 5.4m | 28.8m | 6.0m |
Revenue growth, % | 1302% | |||||||||
General and administrative expense | 29.2m | 36.9m | 28.7m | 18.6m | 14.2m | 8.2m | 9.1m | 10.8m | 11.2m | 22.2m |
R&D expense | 101.7m | 91.4m | 68.5m | 38.3m | 12.9m | 23.7m | 25.2m | 20.7m | 18.0m | 22.7m |
USD | Q2, 2011 | Q3, 2011 | Q1, 2012 | Q2, 2012 | Q3, 2012 | Q1, 2013 | Q2, 2013 | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q1, 2021 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 26.6m | 3.6m | 860.0k | 1.9m | 1.0m | 323.0k | 324.0k | 323.0k | 15.3m | 1.8m | 873.0k | 134.0k | 134.0k | 15.2m | 1.2m | 193.0k | 992.0k | 2.5m | 351.0k | 4.6m | 1.0m | 433.0k | 2.5m | 1.6m | 703.0k | 25.7m | 784.0k | 749.0k | 1.9m |
General and administrative expense | 6.4m | 6.6m | 9.0m | 9.2m | 9.3m | 12.4m | 7.3m | 4.4m | 5.6m | 4.8m | 5.1m | 3.3m | 2.9m | 2.2m | 2.5m | 1.7m | 2.1m | 2.3m | 2.3m | 2.1m | 2.6m | 2.8m | 2.7m | 2.5m | 3.0m | 2.9m | 3.7m | 3.7m | 15.1m |
R&D expense | 25.1m | 20.1m | 24.8m | 21.5m | 21.1m | 21.0m | 16.2m | 19.4m | 11.8m | 9.3m | 8.5m | 2.7m | 1.8m | 4.5m | 6.0m | 5.6m | 4.4m | 8.0m | 6.9m | 4.7m | 5.4m | 4.9m | 5.2m | 6.9m | 2.6m | 4.0m | 7.8m | 4.4m | 5.8m |
Operating expense total | 31.4m | 26.7m | 33.8m | 30.6m | 30.4m | 33.4m | 23.5m | 23.9m | 17.3m | 14.1m | 13.6m | 6.0m | 4.7m | 6.7m | 8.4m | 7.3m | 6.6m | 10.3m | 9.2m | 6.8m | 8.0m | 7.7m | 7.9m | 9.3m | 5.6m | 6.9m | 11.5m | 8.2m | 20.9m |
USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 |
---|---|---|---|---|---|---|---|---|---|---|
Cash | 43.5m | 76.1m | 50.8m | 52.3m | 26.6m | 15.1m | 14.9m | 24.4m | 29.8m | 61.8m |
Accounts Receivable | 7.2m | 20.6m | 984.0k | 2.3m | 4.6m | 1.0m | 402.0k | 3.0m | 1.6m | 1.2m |
Prepaid Expenses | 6.1m | 9.4m | 3.0m | 1.5m | 1.6m | |||||
Current Assets | 234.4m | 190.7m | 128.9m | 59.1m | 40.4m | 26.3m | 50.2m | 27.9m | 50.6m | 65.5m |
USD | Q2, 2011 | Q3, 2011 | Q1, 2012 | Q2, 2012 | Q3, 2012 | Q1, 2013 | Q2, 2013 | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q1, 2021 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | 81.0m | 45.9m | 73.1m | 85.8m | 114.1m | 85.9m | 33.8m | 50.4m | 46.3m | 43.4m | 60.0m | 34.5m | 26.8m | 34.7m | 18.1m | 25.3m | 12.4m | 33.4m | 30.9m | 16.4m | 16.2m | 18.1m | 20.4m | 23.5m | 40.2m | 57.7m | 23.5m | 45.7m | 121.4m |
Accounts Receivable | 28.8m | 9.7m | 9.5m | 9.2m | 9.3m | 9.2m | 7.9m | 8.9m | 1.3m | 1.2m | 1.7m | 947.0k | 2.3m | 2.3m | 1.7m | 1.3m | 990.0k | 676.0k | 445.0k | 2.4m | 600.0k | 973.0k | 344.0k | 2.6m | 611.0k | 1.1m | 2.8m | 1.2m | 1.1m |
Prepaid Expenses | 9.3m | 5.6m | 3.5m | 5.2m | 7.8m | 9.7m | 9.2m | 7.2m | 2.0m | 3.7m | 3.3m | 1.4m | 1.4m | 1.4m | 1.1m | ||||||||||||||
Current Assets | 302.4m | 275.1m | 237.3m | 230.3m | 206.8m | 210.6m | 173.3m | 146.5m | 105.6m | 85.4m | 71.5m | 44.4m | 33.4m | 43.8m | 30.7m | 42.3m | 34.0m | 35.9m | 42.1m | 41.5m | 43.6m | 20.0m | 21.4m | 26.3m | 41.7m | 59.8m | 37.1m | 74.2m | 126.1m |
USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 |
---|---|---|---|---|---|---|---|---|---|---|
Net Income | 30.6m | (114.4m) | (107.0m) | (52.7m) | (15.0m) | (26.9m) | (65.0m) | (5.3m) | 9.4m | (35.6m) |
Depreciation and Amortization | 1.7m | 2.5m | 3.8m | 6.2m | 9.6m | 30.0k | 21.0k | |||
Accounts Payable | (343.0k) | 1.7m | (6.4m) | (993.0k) | (1.8m) | 760.0k | 250.0k | 1.1m | (2.0m) | 1.9m |
Cash From Operating Activities | 26.5m | (105.7m) | (84.4m) | (54.2m) | (18.2m) | (31.1m) | (19.2m) | (25.0m) | (2.9m) | (38.0m) |
USD | Q2, 2011 | Q3, 2011 | Q1, 2012 | Q2, 2012 | Q3, 2012 | Q1, 2013 | Q2, 2013 | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q1, 2021 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 79.6m | 55.8m | (33.2m) | (62.8m) | (92.9m) | (34.1m) | (66.0m) | (90.3m) | (6.4m) | (24.4m) | (38.8m) | (10.9m) | (16.3m) | (8.4m) | (7.7m) | (16.3m) | (21.3m) | (8.8m) | (42.1m) | (68.5m) | (9.0m) | (5.0m) | (27.1m) | 555.0k | (2.6m) | 13.8m | (8.4m) | (15.7m) | (22.1m) |
Depreciation and Amortization | 765.0k | 1.2m | 546.0k | 1.1m | 1.8m | 1.9m | 2.8m | 838.0k | 1.7m | 2.8m | 4.5m | 9.5m | 9.6m | 5.0k | 7.0k | 7.0k | 4.0k | 17.0k | |||||||||||
Accounts Payable | 3.7m | 431.0k | (1.3m) | (4.6m) | 1.4m | (3.4m) | (4.5m) | (1.6m) | (738.0k) | (2.6m) | (626.0k) | (1.7m) | (3.0m) | (1.1m) | 656.0k | (246.0k) | 1.1m | 1.2m | (245.0k) | 944.0k | 386.0k | 547.0k | (1.4m) | (1.5m) | (1.3m) | 1.5m | 319.0k | 583.0k | |
Cash From Operating Activities | 45.5m | 46.4m | (30.6m) | (58.3m) | (82.4m) | (53.5m) | (75.7m) | (19.8m) | (35.2m) | (43.2m) | (15.8m) | (27.2m) | (18.2m) | (10.3m) | (14.9m) | (23.6m) | (5.4m) | (12.4m) | (15.4m) | (6.5m) | (15.6m) | (18.4m) | (8.5m) | (14.5m) | 4.5m | (11.7m) | (19.2m) | (18.3m) |
USD | Q2, 2011 |
---|---|
Financial Leverage | 1.3 x |
AVEO Pharmaceuticals has 1.09k Twitter Followers. The number of followers has increased 1.1% month over month and increased 2% quarter over quarter
289
Tweets
214
Following
1.1k
Followers
10
Tweets last 30 days
3.1
Avg. likes per Tweet
100%
Tweets with engagement
When was AVEO Pharmaceuticals founded?
AVEO Pharmaceuticals was founded in 2001.
Who are AVEO Pharmaceuticals key executives?
AVEO Pharmaceuticals's key executives are Erick Lucera, Kenneth M. Bate and Michael P. Bailey.
How many employees does AVEO Pharmaceuticals have?
AVEO Pharmaceuticals has 19 employees.
What is AVEO Pharmaceuticals revenue?
Latest AVEO Pharmaceuticals annual revenue is $6 m.
What is AVEO Pharmaceuticals revenue per employee?
Latest AVEO Pharmaceuticals revenue per employee is $316.8 k.
Who are AVEO Pharmaceuticals competitors?
Competitors of AVEO Pharmaceuticals include Moleculin Biotech, Plus Therapeutics and Jiangsu Hansoh Pharmaceutical Group.
Where is AVEO Pharmaceuticals headquarters?
AVEO Pharmaceuticals headquarters is located at 30 Winter Pl, Boston.
Where are AVEO Pharmaceuticals offices?
AVEO Pharmaceuticals has an office in Boston.
How many offices does AVEO Pharmaceuticals have?
AVEO Pharmaceuticals has 1 office.
Receive alerts for 300+ data fields across thousands of companies